KHALIL SALIBA: Open Payments
NPI 1679544340 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 12 payments from 7 companies in 2025. Trend: 2023 $963 · 2024 $649 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $108 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
| Corium, LLC | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: INVEGA SUSTENNA, COBENFY, Jornay PM, UZEDY, INGREZZA, Azstarys, Auvelity.
Industry payments across OK — which companies pay providers there.
